Avalo Therapeutics Overview

Life ScienceCompany

Where is Avalo Therapeutics headquartered?

Avalo Therapeutics is headquartered in Rockville, Maryland.

What is Avalo Therapeutics’ revenue?

Avalo Therapeutics disclosed revenue of 2M USD for 2023 and 18M USD for 2022.

How many employees does Avalo Therapeutics have?

Avalo Therapeutics has 23 employees.

What sector is Avalo Therapeutics in?

Avalo Therapeutics is a life science company.

When was Avalo Therapeutics founded?

Avalo Therapeutics was founded in 2011.

Avalo Therapeutics

Avalo Therapeutics, Inc.,

540 Gaither Road, Suite 400,
Rockville, Maryland 20850
United States,
(410) 522-8707
www.avalotx.com

Avalo Therapeutics is a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan diseases, as well as neurological conditions. Avalo Therapeutics, Inc. is building a robust pipeline of innovative therapies. Avalo Therapeutics's pediatric rare disease pipeline is led by CERC-801, CERC-802, and CERC-803 (“CERC-800 programs”), which are therapies for inborn errors of metabolism, specifically disorders known as Congenital Disorders of Glycosylation. The FDA granted Rare Pediatric Disease Designation and Orphan Drug Designation (“ODD”) to all three CERC-800 compounds, thus qualifying the Company to receive a Priority Review Voucher (“PRV”) upon approval of a new drug application (“NDA”). Avalo Therapeutics was founded in 2011 and is based in Rockville, Maryland.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.0/yr) # 1 - - - - - 1
vol $23M $23M
Sell (0.0/yr) # - - - - - - 0
  1

Top M&A Advisors

Legal Deals
Wyrick Robbins
1

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.